Uncovering an Off-the-shelf Peptide-Based Cancer Vaccine
Time: 1:00 pm
day: Day One
Details:
- Highlighting a novel platform used which takes into account the tumour heterogeneity as well as patient heterogeneity
- Evaluating clinical trials which took place in the most difficult-to-treat colorectal cancer (MSS mCRC)
- Showcasing correlation studies for the identification of a candidate predictive biomarker
